S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
US7947721B2 · kind B2 · utility
19Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2005 |
| Grant date | May 24, 2011 |
| Priority date | — |
| Expiry date | Jul 15, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of S-triazolyl α-mercaptoacetanilides having general structure (1) are provided, where Q is CO2H, CONR2, SO3H, or SO2NR2. The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.